Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1311941.RAKXXs_v7cpD6A4ub2jFAI5puNktUcCLjzxHPXSuAL8EE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1311941.RAKXXs_v7cpD6A4ub2jFAI5puNktUcCLjzxHPXSuAL8EE130_assertion type Assertion NP1311941.RAKXXs_v7cpD6A4ub2jFAI5puNktUcCLjzxHPXSuAL8EE130_head.
- NP1311941.RAKXXs_v7cpD6A4ub2jFAI5puNktUcCLjzxHPXSuAL8EE130_assertion description "[Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311941.RAKXXs_v7cpD6A4ub2jFAI5puNktUcCLjzxHPXSuAL8EE130_provenance.
- NP1311941.RAKXXs_v7cpD6A4ub2jFAI5puNktUcCLjzxHPXSuAL8EE130_assertion evidence source_evidence_literature NP1311941.RAKXXs_v7cpD6A4ub2jFAI5puNktUcCLjzxHPXSuAL8EE130_provenance.
- NP1311941.RAKXXs_v7cpD6A4ub2jFAI5puNktUcCLjzxHPXSuAL8EE130_assertion SIO_000772 7545221 NP1311941.RAKXXs_v7cpD6A4ub2jFAI5puNktUcCLjzxHPXSuAL8EE130_provenance.
- NP1311941.RAKXXs_v7cpD6A4ub2jFAI5puNktUcCLjzxHPXSuAL8EE130_assertion wasDerivedFrom befree-2016 NP1311941.RAKXXs_v7cpD6A4ub2jFAI5puNktUcCLjzxHPXSuAL8EE130_provenance.
- NP1311941.RAKXXs_v7cpD6A4ub2jFAI5puNktUcCLjzxHPXSuAL8EE130_assertion wasGeneratedBy ECO_0000203 NP1311941.RAKXXs_v7cpD6A4ub2jFAI5puNktUcCLjzxHPXSuAL8EE130_provenance.